Current
$144B
5-Year Average
$200B
All-Time High
$351B
All-Time Low
$75.7B
Market cap daily chart for Pfizer (PFE)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Pfizer (PFE) from 2017 to 2026
Latest: +1.8%
Market Cap history table for Pfizer (PFE) from 1985 to 2026
| 2026 | $144B | +1.8% | +$2.55B | ||
| 2025 | $142B | -6.4% | -$9.64B | ||
| 2024 | $151B | -8.0% | -$13.1B | ||
| 2023 | $164B | -44.0% | -$129B | ||
| 2022 | $294B | -12.8% | -$43.3B | ||
| 2021 | $337B | +62.6% | +$130B | ||
| 2020 | $207B | -1.6% | -$3.46B | ||
| 2019 | $211B | -14.8% | -$36.6B | ||
| 2018 | $247B | +18.9% | +$39.4B | ||
| 2017 | $208B | +9.7% | +$18.3B | ||
| 2016 | $190B | -1.0% | -$1.83B | ||
| 2015 | $191B | +0.9% | +$1.76B | ||
| 2014 | $190B | -5.3% | -$10.5B | ||
| 2013 | $200B | +12.2% | +$21.8B | ||
| 2012 | $178B | +10.6% | +$17.1B | ||
| 2011 | $161B | +20.4% | +$27.4B | ||
| 2010 | $134B | +10.4% | +$12.6B | ||
| 2009 | $121B | +7.2% | +$8.12B | ||
| 2008 | $113B | -24.2% | -$36.2B | ||
| 2007 | $150B | -16.3% | -$29B | ||
| 2006 | $179B | +9.0% | +$14.7B | ||
| 2005 | $164B | -15.6% | -$30.2B | ||
| 2004 | $194B | -20.5% | -$49.9B | ||
| 2003 | $244B | +34.9% | +$63.1B | ||
| 2002 | $181B | -24.7% | -$59.5B | ||
| 2001 | $240B | -13.5% | -$37.4B | ||
| 2000 | $278B | +43.0% | +$83.5B | ||
| 1999 | $194B | +24.9% | +$38.7B | ||
| 1998 | $156B | +67.1% | +$62.5B | ||
| 1997 | $93.1B | +84.1% | +$42.5B | ||
| 1996 | $50.6B | +34.7% | +$13B | ||
| 1995 | $37.6B | +65.6% | +$14.9B | ||
| 1994 | $22.7B | +7.6% | +$1.6B | ||
| 1993 | $21.1B | -9.3% | -$2.15B | ||
| 1992 | $23.2B | -12.8% | -$3.41B | ||
| 1991 | $26.6B | +118.9% | +$14.5B | ||
| 1990 | $12.2B | +4.0% | +$464M | ||
| 1989 | $11.7B | +22.7% | +$2.17B | ||
| 1988 | $9.54B | +27.7% | +$2.07B | ||
| 1987 | $7.47B | -24.9% | -$2.47B | ||
| 1986 | $9.94B | +20.0% | +$1.66B | ||
| 1985 | $8.28B | — | — |
- 2026$144B+1.8%
- 2025$142B-6.4%
- 2024$151B-8.0%
- 2023$164B-44.0%
- 2022$294B-12.8%
- 2021$337B+62.6%
- 2020$207B-1.6%
- 2019$211B-14.8%
- 2018$247B+18.9%
- 2017$208B+9.7%
- 2016$190B-1.0%
- 2015$191B+0.9%
- 2014$190B-5.3%
- 2013$200B+12.2%
- 2012$178B+10.6%
- 2011$161B+20.4%
- 2010$134B+10.4%
- 2009$121B+7.2%
- 2008$113B-24.2%
- 2007$150B-16.3%
- 2006$179B+9.0%
- 2005$164B-15.6%
- 2004$194B-20.5%
- 2003$244B+34.9%
- 2002$181B-24.7%
- 2001$240B-13.5%
- 2000$278B+43.0%
- 1999$194B+24.9%
- 1998$156B+67.1%
- 1997$93.1B+84.1%
- 1996$50.6B+34.7%
- 1995$37.6B+65.6%
- 1994$22.7B+7.6%
- 1993$21.1B-9.3%
- 1992$23.2B-12.8%
- 1991$26.6B+118.9%
- 1990$12.2B+4.0%
- 1989$11.7B+22.7%
- 1988$9.54B+27.7%
- 1987$7.47B-24.9%
- 1986$9.94B+20.0%
- 1985$8.28B—
Market Cap values are taken from Pfizer's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported market cap is $155B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Pfizer (PFE) came in at $144B – edged up 1.8% year-over-year.
Over 2021–2026 (5 years), Pfizer market cap expanded at a -15.6% compound annual rate, with a net decline across the window.
Pfizer market cap plunged from $337B in 2021 to $144B in 2026, a 57.2% drawdown.
2021 marks the peak market cap at $337B, with the historical low of $7.47B recorded in 1987.
Pfizer Market Cap by Year
Pfizer Market Cap 2026: $144B
2026's market cap for Pfizer came in at $144B, edged up 1.8% from 2025.
Pfizer Market Cap 2025: $142B
Pfizer posted market cap of $142B in 2025, declined 6.4% below 2024.
Pfizer Market Cap 2024: $151B
In 2024, Pfizer reported market cap of $151B, declined 8.0% below 2023.
Pfizer Market Cap 2023: $164B
Pfizer market cap in 2023 was $164B, plunged 44.0% below 2022.
Pfizer Market Cap 2022: $294B
Pfizer market cap in 2022 was $294B.
See more financial history for Pfizer (PFE).
Sector peers by Market Cap
Healthcare peers of Pfizer (PFE), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on PFE
Market Cap — 10 rounds, every one of them PFE against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile6.84% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.